Methods for the control of soybean bacterial pustule disease

Soybean bacterial pustule disease, caused by the pathogen Xanthomonas citri pv. glycines(Xcg), is a recurring issue in soybean cultivation, leading to substantial reductions in yield and quality. Outbreaks have been documented in key soybean-producing regions, including the United States, the Republ...

Full description

Saved in:
Bibliographic Details
Main Author: ZHU Suqin;DONG Yachen;MEI Dezhou;XU Longyu;SHI Xinchi;DUAN Xuchu;WANG Suyan;Pedro LABORDA
Format: Article
Language:English
Published: Editorial Department of Journal of Nantong University (Natural Science Edition) 2025-03-01
Series:Nantong Daxue xuebao. Ziran kexue ban
Subjects:
Online Access:https://ngzk.cbpt.cnki.net/portal/journal/portal/client/paper/d5eebb4abed0ee54b4b1ba5c1f65da50
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Soybean bacterial pustule disease, caused by the pathogen Xanthomonas citri pv. glycines(Xcg), is a recurring issue in soybean cultivation, leading to substantial reductions in yield and quality. Outbreaks have been documented in key soybean-producing regions, including the United States, the Republic of Korea, Thailand, China, and India.This review compiles reported methods for managing Xcg. Control efficacies exceeding 60% have been achieved with the commercial antibiotic oxytetracycline, the bacterial biocontrol agents Pseudomonas parafulva JBCS1880 and Curtobacterium sp. M84, and the natural compounds Biochanin A and thymol. Extracts from Hericium erinaceus and shiitake mushrooms have demonstrated inhibition of Xcg growth in vitro, though their application in planta remains untested. Breeding also emerges as an effective strategy, with resistant soybean varieties significantly reducing disease incidence in the Republic of Korea and the United States. However, data on Chinese soybean cultivars resistant to bacterial pustule disease are scarce. In China, management currently depends heavily on toxic antibiotics, with oxytetracycline being the sole commercially available option among the reported agents.
ISSN:1673-2340